INVESTIGATION PROGRESS
Date | Status |
---|---|
20 Nov 2021 | Termination |
15 Feb 2017 | Definitive duty |
17 Feb 2016 | Initiation |
IMPLEMENTATION LEVEL
NoAFFECTED FLOW
InflowANNOUNCED AS TEMPORARY
YesNON-TRADE-RELATED RATIONALE
NoELIGIBLE FIRMS
JUMBO
NoTARIFF PEAK
NoOn 17 February 2016, the Indian authorities initiated an anti-circumvention investigation on imports of diclofenac sodium from China. This investigation follows suspicion that the definitive antidumping duty imposed by Notification No. 44/2014-Customs (ADD) on 21 November 2014 on imports of the same products originating in China might be circumvented (see related intervention) into India by the exporters of Diclofenac Sodium in China in an unfinished form by way of exports of Indolinone. The products subject to investigation are classified under HS code subheading: 29142990, 29214490, 29224990, 29337900, 29339900, 29081900, 29147090, 29420090, 29333990, 29142990, 29214490, 29224990, 29337900, 29339900, 29081900, 29147090, 29420090 and 29333990. This investigation follows the application lodged by Amoli Organics Ltd.
On 15 February 2017, the Indian authorities extended the definitive antidumping duty imposed on imports of diclofenac sodium from China (see related intervention) to imports of indolinone from China. The rate of duty is USD 2,715 per MT.
The duty was terminated on 20 November 2019.
⚑ Please report this page in case you detect an inaccuracy in its content.